Physician profile
Ahmed Qavi
NPI 1427404565
$12,981.09
in general payments reported to CMS, 2019-2025
27 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $413 · 2021: $1,671 · 2022: $4,883 · 2023: $2,733 · 2024: $3,167 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,351 · Travel and Lodging: $1,315 · Grant: $1,126 · Education: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,350.78 |
| Travel and Lodging | $1,315.23 |
| Grant | $1,126.44 |
| Education | $221.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,507.83 | 2021-2025 | Optis, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $2,191.98 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $668.86 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $531.16 | 2020-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $519.01 | 2022-2024 | Xarelto |
| Medtronic, INC. | $463.06 | 2021-2024 | Symplicity G3, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Shockwave Medical, INC | $447.09 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $445.43 | 2022-2024 | Acticor 7 Vr-T Dx |
| Abiomed | $435.40 | 2020-2023 | Impella |
| Amgen INC. | $335.47 | 2022 | |
| Philips North America LLC | $207.61 | 2024 | (P84) Igt Devices Systems, (Br0) Coronary Atherectomy, (Br3) Coronary Other |
| Irhythm Technologies, INC. | $180.19 | 2021-2022 | |
| Genzyme Corporation | $148.10 | 2022-2023 | |
| Cook Incorporated | $140.85 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $129.89 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $123.55 | 2024 | Indigo System |
| Kiniksa Pharmaceuticals International, Plc | $122.53 | 2024 | Arcalyst |
| Novo Nordisk INC | $74.35 | 2023 | |
| Vital Connect, INC | $63.64 | 2022 | |
| Impulse Dynamics (USA) INC. | $52.83 | 2023 | Optimizer |
| Terumo Medical Corporation | $43.00 | 2023 | Optitorque, Angio-Seal, Glidewire |
| Inari Medical, INC. | $39.32 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alnylam Pharmaceuticals INC. | $32.49 | 2021 | |
| Cvrx, INC. | $27.69 | 2022 | |
| Cardiva Medical, INC. | $20.94 | 2023 | Cardiva Vascade 6/7f Vcs |
| Sanofi-Aventis U.S. LLC | $15.51 | 2023 | |
| Chiesi USA, INC. | $13.31 | 2023 | Kengreal, Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Qavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.